Companies & Industry »Company News»Company News Details
Company News Details

BSE   27 Apr 17 | 04:01 PM

445.10 -8.25 (-1.82%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: 532321
Face Value: N.A.

NSE   27 Apr 17 | 03:59 PM

443.70 -12 (-2.63%)
Mkt Price (Rs)   Chg Rs (Chg %)
1 Week : Rs 449.90 (-1.07%)
1 Month : Rs 452.95 (-1.73%)
1 Year : Rs 327.00 (36.12%)
change companytradenow

Cadila's stock rising: Credit Suisse

Reuters / 18 Jul 12 | 11:50 AM

Credit Suisse initiates coverage on Cadila Healthcare with an "outperform" rating and a target price of Rs 970.

Investment bank says the midcap drug maker has demonstrated "strong execution" in the United States, with a portfolio mix focusing on low competition products such as nasal sprays and injectable drugs.

Widgets Magazine

USFDA approval of its facilities in Moraiya, part of Gujarat, will re-start new approvals of its drugs in the US market, Credit Suisse adds.

"Cadila is moving up the value-chain with the launch of difficult-to formulate products and its strong execution record provides multi-year growth visibility."

Widgets Magazine


Company Price Gain (%)
GAIL (India)418.601.18
Tata Motors455.951.14

Online Portfolio

You can create Online Portfolio here using the below button.

Widgets Magazine